Clinical trials
Recurrence trials in Italy with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute, Naples | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Armando Santoro, MD | 1 |
| Azienda Ospedaliera San Giovanni Battista | 1 |
| Azienda Ospedaliera Universitaria Integrata Verona | 1 |
| Azienda Ospedaliero-Universitaria Careggi | 1 |
| Catholic University of the Sacred Heart | 1 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Gruppo Italiano Studio Linfomi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 20 |
| Carcinoma, Hepatocellular | 2 |
| Lymphoma | 2 |
| Neoplasm Metastasis | 2 |
| Central Nervous System Diseases | 1 |
| Colonic Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
| Fever | 1 |
| Head and Neck Neoplasms | 1 |
| Hemorrhoids | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.